- M&A – Commended
- PRODUCT LAUNCHES – Commended
- RESEARCH AND DEVELOPMENT – Commended
- SAFETY – Commended
Medical Device Technology Excellence Awards and Rankings 2022 – The Verdict
Medtronic is a medical device company that is ranked for M&A, Product Launches, Research and Development and Safety in the 2022 Medical Device Network Excellence Rankings.
During the research period Medtronic focused on invasive treatment devices launching two balloon catheter systems. Prevail DCB, which is intended for use in coronary interventions and NuVent, which is meant for eustachian tube dysfunction. Freezor.
Another of Medtronic’s catheter systems, meant to treat paediatric AVNRT, has recently received the green light from the FDA, while across the pond EU authorities have given Medtronic’s Hugo surgery system the CE mark. To strengthen even further its position in the invasive treatment sector the company also acquired Intersect ENT.
During the research period Medtronic focused on invasive treatment devices launching two balloon catheter systems
The company has also been active in the field of cardiovascular solutions. The FDA approved Medtronic’s AI algorithms for cardiac monitoring and the American multinational also acquired Affera, a company with an extensive cardiac ablation portfolio.
The company also made advancements in the field of neurostimulation devices, with its neurostimulators for DPN (diabetic peripheral neuropathy) chronic pain treatment receiving FDA approval and first reports from their tibial neuromodulation device trial coming out positive.
Medtronic is a medical technology company that designs, develops, manufactures and markets a wide range of medical devices and solutions.
It offers products for the treatment of heart valve disorders, heart failure, diseases of the coronary artery, aortic, peripheral vascular, venous renal and neurological diseases, spine and musculoskeletal disorders and diseases of the ear, nose, and throat. It also provides biologic solutions for the orthopedic and dental markets.
In the US, the company sells its products through direct sales force, and in other countries, through direct sales representatives and independent distributors. It offers its products to hospitals, third-party healthcare providers, clinics, institutions including governmental health care programs, distributors, and group purchasing organizations in Asia Pacific, Europe, the Americas, the Middle East and Africa. Medtronic is headquartered in Dublin, Ireland.